Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-062035

Chief Executive Officer sold 83,333 shares at $63.50 ($5,291,646)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2019-12-24 Sale −83,333 $63.50 $5,291,646 1,805,237 D
Open-market sales · 83,333 sh · avg $63.50 · $5,291,646
Loading xslF345X03/doc4.xml…